Shandong Wit Dyne HealthLtd (000915) Stock Overview
Engages in the pharmaceutical business in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
000915 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Shandong Wit Dyne Health Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥32.95 |
| 52 Week High | CN¥35.74 |
| 52 Week Low | CN¥23.61 |
| Beta | -0.024 |
| 1 Month Change | 14.05% |
| 3 Month Change | 9.32% |
| 1 Year Change | 12.15% |
| 3 Year Change | -19.24% |
| 5 Year Change | 0.24% |
| Change since IPO | 296.89% |
Recent News & Updates
Recent updates
Is There An Opportunity With Shandong Wit Dyne Health Co.,Ltd.'s (SZSE:000915) 38% Undervaluation?
Oct 27
There's No Escaping Shandong Wit Dyne Health Co.,Ltd.'s (SZSE:000915) Muted Earnings
Sep 14Shandong Wit Dyne HealthLtd (SZSE:000915) Is Increasing Its Dividend To CN¥2.00
May 12Shandong Wit Dyne HealthLtd's (SZSE:000915) Earnings Offer More Than Meets The Eye
Apr 24Shareholder Returns
| 000915 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 1.4% | 3.0% | 0.4% |
| 1Y | 12.2% | 27.6% | 24.8% |
Return vs Industry: 000915 underperformed the CN Pharmaceuticals industry which returned 27.5% over the past year.
Return vs Market: 000915 underperformed the CN Market which returned 25.6% over the past year.
Price Volatility
| 000915 volatility | |
|---|---|
| 000915 Average Weekly Movement | 5.2% |
| Pharmaceuticals Industry Average Movement | 5.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in CN Market | 8.6% |
| 10% least volatile stocks in CN Market | 2.9% |
Stable Share Price: 000915 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000915's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 1,759 | Jie Yang | www.sd-wit.com |
Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets.
Shandong Wit Dyne Health Co.,Ltd. Fundamentals Summary
| 000915 fundamental statistics | |
|---|---|
| Market cap | CN¥7.72b |
| Earnings (TTM) | CN¥529.31m |
| Revenue (TTM) | CN¥2.18b |
Is 000915 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000915 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.18b |
| Cost of Revenue | CN¥387.53m |
| Gross Profit | CN¥1.79b |
| Other Expenses | CN¥1.26b |
| Earnings | CN¥529.31m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Aug 08, 2025
| Earnings per share (EPS) | 2.26 |
| Gross Margin | 82.22% |
| Net Profit Margin | 24.29% |
| Debt/Equity Ratio | 0% |
How did 000915 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/15 02:17 |
| End of Day Share Price | 2025/07/15 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shandong Wit Dyne Health Co.,Ltd. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Chao Li | Citic Securities Co., Ltd. |
| Mingrui Wang | Everbright Securities Co. Ltd. |
| Yuan Yuan Sun | Industrial Securities Co. Ltd. |